Showing results for "#first triple fixed-dose combination"

Glenmark launches drug for treating type 2 diabetes

According to a statement from Glenmark released on Wednesday, Teneligliptin is a widely-used Dipeptidyl Peptidase 4 inhibitor. Dipeptidyl peptidase 4...